house of lords official report - United Kingdom Parliament
house of lords official report - United Kingdom Parliament
house of lords official report - United Kingdom Parliament
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
1129 Organophosphates<br />
[17 JUNE 2009]<br />
Organophosphates<br />
1130<br />
glaucoma are all in this group and the first two are, to<br />
my knowledge, also caused by OP damage to the<br />
autonomic system.<br />
Is the Minister able to say how much research<br />
has been conducted into the effects that drugs which<br />
act on the acetylcholine system have on patients who<br />
have <strong>report</strong>ed illness following exposure to<br />
organophosphate pesticides? If he knows <strong>of</strong> none,<br />
does he agree that this is an important consideration<br />
for a large number <strong>of</strong> agricultural workers, Gulf War<br />
veterans and aircrew? Should this not be an urgent<br />
consideration?<br />
I have made a brief outline <strong>of</strong> some <strong>of</strong> the reasons<br />
why I believe that the Official Group on<br />
Organophosphates should reconvene. I have barely<br />
touched on recent developments in this field. I have<br />
asked that it should give the matter priority. I also ask<br />
that on this occasion it produces a <strong>report</strong> on the lines<br />
<strong>of</strong> its 1998 <strong>report</strong>.<br />
7.41 pm<br />
Lord Rooker: My Lords, I support the noble Countess.<br />
Basically, the simple answer to her question should be<br />
yes. I am not going to go into all the background<br />
details because I am not as up-to-date as I was when I<br />
was one <strong>of</strong> the Ministers responsible in 1997-99 and<br />
then again from 2006-08 in one department, but the<br />
fact that this issue goes across departments is the<br />
central point that I wish to make.<br />
As the noble Countess has said, there has been<br />
progress. The lack <strong>of</strong> exposure today is a result <strong>of</strong><br />
the work that has been done by the industry,<br />
pushed by our <strong>of</strong>ficials in the Veterinary Medicines<br />
Directorate, in producing better containers from<br />
which people could not by accident, irrespective <strong>of</strong><br />
negligence, be contaminated. There is no question that<br />
this was a serious issue in the past. However, this<br />
means that no new people from farming are coming<br />
into the system for the doctors and the scientists to<br />
look at. As I say, the problem transcends that, but<br />
there has been stagnation.<br />
When we considered this problem in MAFF from<br />
very early on in 1997 and 1998, I had discussions with<br />
the then Minister, Jack Cunningham, who, with his<br />
background as a chemist, took it very seriously. We<br />
picked up from other departments that there were<br />
issues across government in regard to chemicals. Richard<br />
Carden—who, as the noble Countess said, has retired—<br />
would take some pleasure in seeing the Carden Committee<br />
reconvened. He was a first-class civil servant, in my<br />
experience, at MAFF and he chaired a large Whitehall<br />
committee which covered many more departments<br />
than one would imagine. Obviously, as I moved around<br />
Whitehall I did not keep up to date over the years. I<br />
regret that the committee’s deliberations have not been<br />
made public and I can see no good reason for that.<br />
In that period <strong>of</strong> time, we had probably three<br />
scientific advisers, and now we have a new Government<br />
Chief Scientific Adviser. This problem should be the<br />
first thing on Pr<strong>of</strong>essor Bennington’s desk and he<br />
should look at it to see what the current situation is.<br />
There are grounds for considering it. I have never seen<br />
a satisfactory answer to the issue <strong>of</strong> the airline pilots<br />
and the doubts that have been raised about it. I do not<br />
want to be controversial but, if one looks at the big<br />
picture from the outside—at the nature <strong>of</strong> the doubts<br />
about organophosphates, at the issue <strong>of</strong> Factor VIII,<br />
dirty blood and blood products, and at the issue <strong>of</strong><br />
Gulf War syndrome from the first Gulf War—one<br />
gets the impression <strong>of</strong> a natural reluctance <strong>of</strong> the<br />
centre to investigate when these issues arise and a<br />
pattern starts to be formed. That is the point that I<br />
want to make.<br />
In a way, the Carden Committee and what was put<br />
together could overcome and answer some <strong>of</strong> these<br />
issues. They go across Whitehall departments. I do not<br />
want the Government to be in the dock over them but<br />
a pattern has emerged over a period—there may be<br />
others <strong>of</strong> which I am unaware—that there is a reluctance<br />
to investigate. Why? “Oh, because there are no new<br />
cases; because <strong>of</strong> the issue <strong>of</strong> compensation; because<br />
the science is not quite clear”. Given what has happened<br />
in the <strong>United</strong> States in the first 100 days, if these<br />
matters were put to President Obama I can envisage<br />
some executive action coming forth. Not by overdoing<br />
the science or taking the scientists’ view, but by giving the<br />
issue a push, a spurt, to ensure that we can put it to<br />
bed.<br />
There is plenty <strong>of</strong> evidence—I do not think complete<br />
solutions will ever be found—from those who have<br />
been injured, if I can put it that way, in the farming<br />
industry, from those with Gulf War syndrome and<br />
from the issue <strong>of</strong> the fuel used in aircraft to ensure that<br />
the doubts about the use <strong>of</strong> organophosphates remain.<br />
These are matters worthy <strong>of</strong> investigation. In the way<br />
that it does, Whitehall did some joined-up thinking on<br />
this. There was genuine joined-up working in the way<br />
in which the Carden Committee was put together and<br />
worked. I pay tribute to that and I have no problem<br />
with it.<br />
I was on the receiving end over a 10-year period <strong>of</strong><br />
delegations which included the noble Lord, Lord Taylor,<br />
and the noble Countess, Lady Mar. I said to <strong>of</strong>ficials<br />
on one occasion—I think it was in 2006 or early<br />
2007—after the noble colleagues had left, “One day I<br />
will be a Back-Bencher and she is my model”. That is<br />
true. The noble Countess has shown great tenaciousness<br />
in pushing this issue—it is not a vested interest, although<br />
she has been affected in many ways—getting to grips<br />
with it and not accepting no for an answer. In this<br />
case, Whitehall and the Government reached out.<br />
I do not know whether it is time to call for Carden,<br />
who is well away into retirement—I shall not mention<br />
what part <strong>of</strong> the country he is in but I had a nice letter<br />
from him when I left government, so I know he keeps a<br />
watch on what is going on—but I hope the lawyers will<br />
not make the final decision; it is important that it is<br />
made on the grounds <strong>of</strong> science and health. The<br />
Government have a public responsibility and a duty <strong>of</strong><br />
care in all these issues. In allowing products onto the<br />
market, however they are used, the Government have<br />
a duty <strong>of</strong> care. It may be that people will say, “We have<br />
solved all the problems” but, nevertheless, there are<br />
too many unanswered questions. It is probably time,<br />
given the Whitehall committee structure, genuinely to<br />
say to the noble Countess tonight that the answer to<br />
her question should be yes.